Compare FTV & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTV | DVA |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | 18000 | N/A |
| Industry | Industrial Machinery/Components | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9B | 14.9B |
| IPO Year | 2015 | 2003 |
| Metric | FTV | DVA |
|---|---|---|
| Price | $60.36 | $184.05 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 8 |
| Target Price | $62.79 | ★ $219.86 |
| AVG Volume (30 Days) | ★ 1.8M | 577.2K |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | ★ 0.47% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.44 | ★ 6.86 |
| Revenue | $6,452,700,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | $5.08 | $3.77 |
| Revenue Next Year | $3.82 | $3.39 |
| P/E Ratio | $136.34 | ★ $27.19 |
| Revenue Growth | ★ 12.10 | 6.46 |
| 52 Week Low | $48.98 | $101.00 |
| 52 Week High | $64.56 | $247.49 |
| Indicator | FTV | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 67.30 | 53.11 |
| Support Level | $57.97 | $173.98 |
| Resistance Level | $60.79 | $202.63 |
| Average True Range (ATR) | 1.18 | 5.66 |
| MACD | 0.40 | 0.65 |
| Stochastic Oscillator | 90.88 | 68.13 |
Fortive Corp is a diversified industrial technology firm offering essential technologies, software, and services globally across several industries, such as manufacturing, utilities, medical, electronics, etc. It has two reportable segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Maximum revenue is generated from the Intelligent Operating Solutions segment, which offers professional instruments used in applications like maintenance, repair, measurement, and condition monitoring, connected worker safety, compliance solutions, etc. The products and services in this segment are marketed under various brands, including Fluke, Servicechannel, Gordian, Accruent, Industrial Scientific, and Intelex. Geographically, the firm generates maximum revenue from North America.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.